1. Home
  2. SAIC vs TLX Comparison

SAIC vs TLX Comparison

Compare SAIC & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAIC
  • TLX
  • Stock Information
  • Founded
  • SAIC 1969
  • TLX 2015
  • Country
  • SAIC United States
  • TLX Australia
  • Employees
  • SAIC N/A
  • TLX N/A
  • Industry
  • SAIC EDP Services
  • TLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SAIC Technology
  • TLX Health Care
  • Exchange
  • SAIC Nasdaq
  • TLX Nasdaq
  • Market Cap
  • SAIC 5.1B
  • TLX 6.0B
  • IPO Year
  • SAIC N/A
  • TLX N/A
  • Fundamental
  • Price
  • SAIC $112.53
  • TLX $17.24
  • Analyst Decision
  • SAIC Buy
  • TLX Strong Buy
  • Analyst Count
  • SAIC 8
  • TLX 1
  • Target Price
  • SAIC $142.25
  • TLX $22.00
  • AVG Volume (30 Days)
  • SAIC 1.1M
  • TLX 33.0K
  • Earning Date
  • SAIC 03-17-2025
  • TLX 01-01-0001
  • Dividend Yield
  • SAIC 1.31%
  • TLX N/A
  • EPS Growth
  • SAIC N/A
  • TLX 798.14
  • EPS
  • SAIC 7.17
  • TLX 0.09
  • Revenue
  • SAIC $7,479,000,000.00
  • TLX $484,687,790.00
  • Revenue This Year
  • SAIC $4.13
  • TLX N/A
  • Revenue Next Year
  • SAIC $2.52
  • TLX N/A
  • P/E Ratio
  • SAIC $15.69
  • TLX $190.59
  • Revenue Growth
  • SAIC 0.47
  • TLX 55.85
  • 52 Week Low
  • SAIC $94.68
  • TLX $14.01
  • 52 Week High
  • SAIC $156.34
  • TLX $30.36
  • Technical
  • Relative Strength Index (RSI)
  • SAIC 59.09
  • TLX N/A
  • Support Level
  • SAIC $108.31
  • TLX N/A
  • Resistance Level
  • SAIC $109.69
  • TLX N/A
  • Average True Range (ATR)
  • SAIC 4.28
  • TLX 0.00
  • MACD
  • SAIC 0.58
  • TLX 0.00
  • Stochastic Oscillator
  • SAIC 55.61
  • TLX 0.00

About SAIC SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, the company offers engineering, systems integration, and information technology for large government projects and a broad range of services with an emphasis on higher-end technology services. The company's end-to-end enterprise IT offerings span the entire spectrum of customers' IT infrastructure.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: